SCHEMBL1435232

SCHEMBL1435232

O=C(C=Cc1ccccc1)c1nc(-c2ccccc2)c(-c2ccccc2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.54
LMNA P02545 5/20 0.54
ALDH1A1 P00352 4/20 0.54
KMT2A Q03164 3/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ATM Q13315 1/20 0.54
PTGS1 P23219 2/20 0.47
MEN1 O00255 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP1B1 Q16678 3/20 0.46
PLIN1 O60240 2/20 0.46
RECQL P46063 2/20 0.46
PLIN5 Q00G26 2/20 0.46
ABHD5 Q8WTS1 2/20 0.46
BCHE P06276 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1435545 0.92 ALDH1A1 (0.55) MAPTLMNAALDH1A1KMT2ARAB9A
SCHEMBL1435549 0.92 ALDH1A1 (0.55) MAPTLMNAALDH1A1KMT2ARAB9A
SCHEMBL1435330 0.87 PTPN1 (0.57) MAPTLMNAALDH1A1KMT2ASMN1; SMN2
SCHEMBL1435486 0.84 MAPT (0.56) MAPTLMNAALDH1A1KMT2ARAB9A
SCHEMBL5924855 0.78 ALDH1A1 (0.55) MAPTALDH1A1KMT2ASMN1; SMN2PTGS1
Hydrochloric Acid SCHEMBL11231052 0.77 PTGS2 (0.56) MAPTALDH1A1KMT2ASMN1; SMN2PTGS1
SCHEMBL12127937 0.75 ALDH1A1 (0.56) MAPTALDH1A1KMT2ARAB9ASMN1; SMN2
SCHEMBL11224795 0.75 ALDH1A1 (0.51) MAPTALDH1A1KMT2ASMN1; SMN2PTGS1
SCHEMBL1249616 0.74 ADORA3 (0.51) MAPTLMNAALDH1A1KMT2ARAB9A
SCHEMBL27621009 0.71 XIAP (0.55) MAPTALDH1A1KMT2ASMN1; SMN2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898908-B1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT TROPHOS (FR) 2011-03-30 EP claimed
EP-1898908-B1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT TROPHOS (FR) 2011-03-30 EP disclosed
US-20090203747-A1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE TROPHOS PARC SCIENTIFIQUE LUMINY (FR) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203747-A1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE NLN, NQO1, APP MAPT 31/4885LMNA 2447/4885ALDH1A1 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.